Male Infertility Industry Key Companies are Sanofi, Bayer Group, and SCSA Diagnostics

Posted on 2023-07-24 by researchinsights in Biotech, Healthcare, Industrial, Pharmaceuticals, Technology // 0 Comments

Male Infertility Industry Data Book – Male Infertility Industry Data Book – Male Infertility Diagnosis and Male Infertility Treatment Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030

Grand View Research’s male infertility industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with a digital healthcare statistics e-book.

Access the Global Male Infertility Industry Data Book, 2023 to 2030, compiled with details like trade data, pricing intelligence, and competitive benchmarking.

Male Infertility Diagnosis Market Report Highlights

The global male infertility diagnosis market size was valued at USD 343.8 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.89% from 2023 to 2030.

A study published in the Journal of Urology in 2020 mentioned that the prevalence of male infertility in the U.S. was around 15%. This can be attributed to the increase in consumption of alcohol, smoking, obesity, stress, and lifestyle changes.
Studies have shown that smoking can damage sperm DNA, reduce sperm motility & count, and increase the percentage of abnormal sperm.
Microscopic examination is an important diagnostic test for male infertility. It involves the analysis of a semen sample under a microscope to evaluate the quantity, quality, and motility of sperm. The test can help identify issues such as low sperm count, poor sperm motility, and abnormal sperm morphology.
Based on diagnosis techniques, DNA fragmentation test accounted for the largest share of 21.76% of the diagnosis market in 2022, due to its ability to provide reliable analysis of sperm DNA integrity. It is also expected to exhibit the strongest growth during the forecast period.

Order your copy of Free Sample of “Male Infertility Industry Data Book – Male Infertility Diagnosis and Male Infertility Treatment Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030” Data Book, published by Grand View Research

Male Infertility Treatment Market Report Highlights

The global male infertility treatment market is valued at USD 3.68 billion as of 2022 and is expected to expand at a CAGR of 4.86% for the forecast period 2023-2030.

High adoption of Assisted Reproductive Technology (ART) is a significant driver for the male infertility market. The increasing awareness and acceptance of ART have led to a surge in demand for these procedures.
In 2022, ART dominated the market with a revenue share of 71.11% and is likely to maintain its lead during the forecast period.
Drugs and hormonal therapy are preferred for initial treatment.
The use of Preimplantation Genetic Testing (PGT) has resulted in higher success rates of IVF procedures by helping identify chromosomally normal embryos. Hence, as a result of the aforementioned factors, the male infertility market may grow over the forecast period.

Go through the table of content of Male Infertility Industry Data Book to get a better understanding of the Coverage & Scope of the study

Competitive Landscape

Development of innovative technologies, acquisitions, and partnerships or collaborations for the development & commercialization of products are some of the key strategies undertaken by companies to remain competitive in the market. For instance, in October 2022, Endo International plc and the Sexual Medicine Society of North America (SMSNA) reported the launch of Peyronie’s Self-Assessment app. Moreover, market players are availing certification from regulatory agencies to strengthen their position in the market.

Key players operating in the Male Infertility industry are:

EMD Serono, Inc.
Endo International plc
Sanofi
Bayer Group
SCSA Diagnostics
Halotech DNA SL

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Matched content

Editor’s pick